John W. Dolan

John W. Dolan

John Dolan has been writing "LC Troubleshooting" for LCGC for over 25 years. One of the industry's most respected professionals, John is currently a principal instructor for LC Resources, Walnut Creek, California He is also a member of LCGC's editorial advisory board.

Articles by John W. Dolan

LCGC_Lloyd Snyder 1.jpg

LCGC Europe

Lloyd Snyder was one of perhaps ten “founding fathers” of high performance liquid chromatography (HPLC), with seminal publications in most areas, including adsorption (normal phase), reversed phase, isocratic, gradient, and preparative chromatography; plus solvent, temperature, and column selectivity. With nine books, several hundred publications, and an h-index of 83, he was one of the most widely cited chromatographers and received many of the most prestigious awards in separation science.

LCGC6_i1.jpg

LCGC North America

Lloyd Snyder was one the “founding fathers” of high performance liquid chromatography (HPLC). He was one of the most widely cited chromatographers with many important contributions to the field of separation science.

LCGC7_i1.jpg

LCGC North America

In advance of PittconIn advance of Pittcon 2018, leading scientists-Ronald Majors, Richard Henry, John W. Dolan, Zachary S. Breitbach, and Daniel W. Armstrong-who will be speaking at the LCGC awards symposium give us a preview of their talks.

LCGC North America

In his final column before retirement, John Dolan reflects on the changes he has seen during his 34 years as the author of “LC Troubleshooting,” and shares his short list of best practices that still hold true today.

benefit.png

LCGC Europe

In his final column before retirement, John Dolan reminisces about his years as the author of “LC Troubleshooting”, and some of the changes that have taken place in liquid chromatography (LC) technology during that time.

Offer.png

LCGC Asia Pacific

When you want to adjust a United States Pharmacopeia (USP) method for a different size column or to meet system suitability criteria that fail, how much of a change can you make without revalidating the method?

offer.png

LCGC Europe

When you want to adjust a United States Pharmacopeia (USP) method for a different size column or to meet system suitability criteria that fail, how much of a change can you make without revalidating the method?